PPC
BMY icon

Park Place Capital’s Bristol-Myers Squibb BMY Stock Holding History

Park Place Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Buy
3,929
+2,579
+191% +$150K 0.05% 180
2025
Q4 		$72.8K Buy
1,350
+11
+0.8% +$529 0.02% 278
2025
Q3 		$60.4K Sell
1,339
-181
-12% -$8.45K 0.01% 300
2025
Q2 		$72.2K Sell
1,520
-9,852
-87% -$484K 0.02% 295
2025
Q1 		$694K Sell
11,372
-1,391
-11% -$81.1K 0.19% 93
2024
Q4 		$722K Sell
12,763
-599
-4% -$33.5K 0.2% 101
2024
Q3 		$691K Buy
13,362
+4,509
+51% +$212K 0.2% 105
2024
Q2 		$368K Buy
8,853
+114
+1% +$5.1K 0.12% 157
2024
Q1 		$474K Buy
8,739
+5,083
+139% +$259K 0.17% 139
2023
Q4 		$188K Sell
3,656
-1,767
-33% -$92.8K 0.07% 230
2023
Q3 		$315K Sell
5,423
-1,900
-26% -$116K 0.09% 181
2023
Q2 		$468K Buy
7,323
+1,587
+28% +$106K 0.13% 151
2023
Q1 		$398K Buy
5,736
+526
+10% +$37.1K 0.11% 170
2022
Q4 		$375K Buy
+5,210
New +$393K 0.11% 173

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Park Place Capital's BMY Position: Q1 2026 in Review

Park Place Capital increased its Bristol-Myers Squibb (BMY) stake by 191% in Q1 2026, buying an estimated $150K and bringing the position to 3,929 shares worth $238K. The position accounts for 0.05% of the portfolio, ranked #180.

Park Place Capital first reported a position in BMY in Q4 2022 and has held it in 14 quarters since. The position peaked at $722K in Q4 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Park Place Capital held 3,929 shares of Bristol-Myers Squibb worth $238K as of Q1 2026.
  • Park Place Capital bought 2,579 Bristol-Myers Squibb shares in Q1 2026, an estimated $150K.
  • Bristol-Myers Squibb made up 0.05% of Park Place Capital's portfolio in Q1 2026, its #180 holding.
  • Park Place Capital first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's Bristol-Myers Squibb position peaked at $722K in Q4 2024.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Park Place Capital's 13F filing for Q1 2026, filed 9 Apr 2026.